Background: Immune pressure by cytotoxic T lymphocytes (CTLs) induces escape mutations and immune evasion in HIV-1 infection, and the persistence of escape variants shapes HLA-associated viral diversity at the population level. Previous studies with Caucasian and African cohorts showed that HLA-associated Gag polymorphisms impose fitness cost and that Gag-Protease mediated viral replication capacity (Gag-Pro RC) is compromised in patients with protective HLA alleles. However, the protective alleles reported in Caucasian/Africa cohorts, including B*57:01, are not prevalent in Japan. Therefore, factors associated with protection are likely to be different in Asian populations due to different HLA distributions. Moreover, the role of Gag in HIV-1 disease progression has not been well defined in the Asian populations. To address these issues, we investigated HLA-associated changes in Gag-Pro RCs in a Japanese cohort.
Methods: We generated chimeric HIV-1NL4-3 carrying gag-protease derived from 330 treatment-naive Japanese individuals who are chronically infected with HIV-1 subtype B. Replication capacities of chimeric viruses were determined by infecting CEM-GXR cells in vitro, which are engineered to express LTR-GFP, CCR5, and CXCR4. Subsequently, we examined the association of Gag-Pro RCs with clinical markers of HIV infection and the impact of patients’ HLA alleles on Gag-Pro RCs.
Results: In contrast to Caucasian- and African-cohort studies, patients with higher Gag-Pro RCs showed only a weak tendency toward higher viral load (VL) and lower CD4 count. We did not observe statistically significant associations. Even though previous studies with Caucasian and African cohorts reported a stronger association of Gag-Pro RCs with patients’ VL in the presence of protective HLA alleles such as HLA-B*57, our data indicated that subjects who did not carry Japanese-specific protective alleles, HLA-B*52 and -B*67, showed a statistically significant association between Gag-Pro RCs and VL. Furthermore, we found six locations in the Gag-Protease region, four of which was negatively correlated and the other two positively correlated with VL.
Conclusions: Taken together, our data suggested the impact of Gag-Pro dependent replication on HIV-1 disease progression in the absence of a protective immune pressure. The results also implied a different mechanism of HLA-induced changes in Gag-Pro RCs and their impact on clinical outcomes in the Japanese population compared to Caucasian and African cohorts.